NL-OMON53723尚未招募不适用
Antipsychotics: about Safety, Acceptation and Pharmacokinetics in adults - ASAP
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- Age >= 18 years
- •- Written informed consent has been obtained from the patient
- •- Using an antipsychotic
- •- Scheduled for metabolic screening according to standard clinical care
排除标准
- •- Unable to draw samples for study purposes
- •- Language barriers
- •- Unable to give informed consent to all aspects of the study
研究者
相似试验
招募中
不适用
Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCTAutism Spectrum DisorderNL-OMON23089Erasmus Medical Center Rotterdam140
已完成
不适用
Safety and pharmacokinetics of antipsychotics in children with autismAutism Spectrum Disorder (autisme spectrum stoornis)NL-OMON22814Erasmus Medical Center Rotterdam90
已完成
不适用
Safety and pharmacokinetics of antipsychotics in children with autismbehavioral disturbances10034726autismNL-OMON47545Erasmus MC, Universitair Medisch Centrum Rotterdam150
进行中（未招募）
1 期
Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCTAutism spectrum disorderCTIS2024-511568-96-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)280
已完成
不适用
Atypical antipsychotics for continuation and maintenance treatment after an acute manic episodeMental and Behavioural DisordersBipolar disorderISRCTN76555175niversity of British Columbia (Canada)540